10times
11 Nov 2020Ended

Webinar: Cell and Gene Therapy - CMC Challenges and Strategies

AboutSpeakersExhibitorsReviewsPhotos

Estimated Turnout

upto 100
Delegates
Based on previous editions

Editions

11 Nov 2020

Frequency

Not Available
Claim event to edit details

In this webinar, experts from Cardinal Health Regulatory Sciences discuss CMC challenges and potential mitigation strategies illustrated through .. Read more multiple case studies. Cell and gene therapy developers, research scientists, regulatory and legal professionals are all encouraged to attend. Chemistry, manufacturing, and controls (CMC) is an integral aspect of cell and gene therapy development. Cell and gene therapy development presents unique CMC challenges because of inherent properties such as shorter shelf life, variability in starting and ancillary materials, manufacturing and logistical complexities, and cost. FDA cell and gene therapy information requests often contain more CMC related inquiries than traditional products. In her current role at Cardinal Health Regulatory Sciences, she focuses on providing CMC regulatory consulting and strategy in the cell and gene therapy area. Her role includes helping clients in FDA meeting preparation (INTERACT, pre-IND), authoring Module 3 quality sections, preparation of information request (IR) responses and authoring of biologics master files.

  • Share your Experience
  • Organizer
Logo Follow Company

Questex Media Group Inc. Top Rated

USA 231 Total Events / 20 Upcoming Events 85+ Followers

More Events From The Organizer